Abstract
Factor VII levels as measured in one stage clotting assays are dependent on the degree of activation of factor VII and on the type of thromboplastin used. Bovine thromboplastin (BT) is known to be more sensitive to factor VIIa than human brain thromboplastin and the different sensitivities of these reagents to VIIa have formed the basis of a method for determining VIIa in plasma (16). Since human thromboplastin is no longer widely available, we have re-evaluated this method using bovine and two rabbit thromboplastins (Manchester Reagent, RT MR and Diagen activated, RT Diagen). Activated factor VII was generated in normal plasma by cold activation for 24 hours. During this period, factor VII assays using bovine thromboplastin increased markedly with time whereas the assays using rabbit thromboplastins showed considerably less change. The ratio of factor VII (bovine thromboplastin)/factor VII (rabbit thromboplastin) is a sensitive index of activated factor VII in plasma. The mean ratio in normal plasmas (using BT and RT MR) was found to be 1.02 (± 2 s.d., range 0.80–1.24). The ratio was measured in 29 samples from patients with disseminated intravascular coagulation (D.I.C.) and was found to be increased in 24 (mean 1.71, range 0.93–3.38).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
